In the microscopic world of bacteria, gene transfer is a powerful mechanism that can alter cellular function, drive antibiotic resistance and even shape entire ecosystems.

With the long-term goal of creating living cells from non-living components, scientists in the field of synthetic biology work with RNA origami. This tool uses the multifunctionality of the natural ...

Completed dosing of first two cohorts in Phase 1/2a REWRITE Clinical Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD); Interim ...

But real lightning would have struck infrequently—and mostly in open ocean, where organic compounds would have quickly ...

University at Albany researchers at the RNA Institute are pioneering new methods for designing and assembling DNA nanostructures, enhancing their potential for real-world applications in medicine, ...

Assembling DNA nanostructures at more moderate temperatures opens up the possibility of using the structures in biomedical ...

University at Albany researchers at the RNA Institute are pioneering new methods for designing and assembling DNA ...

Imagine a world where we could predict the behavior of life just by analyzing a sequence of letters. This is not science ...

Researchers at the RNA Institute at the University at Albany are pioneering new methods for designing and assembling DNA ...

BMO Capital initiated coverage of Avidity Biosciences (RNA) with an Outperform rating and $72 price target Avidity’s pipeline includes ...

The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...

Beam Therapeutics announced positive initial data for BEAM-302 in the Phase I/II trial in Alpha-1 Antitrypsin Deficiency (AATD).